Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arikayce in Bronchiectasis with Chronic Pseudomonas Infection
NCT00775138Phase 2Completed
- Sponsor
- Insmed Incorporated
- Start
- Jun 2008
- Primary completion
- May 2009
- Countries
- 9
01
Overview
A Phase 2 trial of amikacin liposome inhalation suspension in Pseudomonas aeruginosa infection, sponsored by Insmed Incorporated. Started Jun 2008; status: completed.
02
Drugs
amikacin liposome inhalation suspension
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00775138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775138.